Clinical Trial Update: Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating memantine add-on in bipolar disorder type I patients who are nonresponders or partial responders; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: University of Sao Paulo | Conditions: Bipolar Disorder | Phase 2 | Status: UNKNOWN